Alvotech shares rose after the company said the Food and Drug Administration approved a new manufacturing process for Simlandi, its biosimilar to Humira. The stock was 8% higher, at $5.41, in morning ...
In advance of November 10, 2026 GDUFA goal date, three commercial lots of Preservative-Free Ketamine have been successfully ...
Alvotech ( ALVO) announced that the U.S. FDA has approved a new manufacturing process for SIMLANDI (adalimumab-ryvk), the company's biosimilar version of Humira, allowing production using an upgraded ...
Drug manufacturing process models represent a "growing area" of scientific development and have been utilized in new drug applications (NDAs), biologics license applications (BLAs), and supplements to ...
Pharmaceutical Formulation Science Moves From Lab Bench to Production Line in Landmark Special Issue
A new Journal of Pharmaceutical Investigation special issue curated by three Korean guest editors will highlight ...
Even when AI designs molecules with potential as medicines, drug development can be delayed if the process of producing them ...
New draft guidance issued by the US Food and Drug Administration (FDA) is intended to clarify which changes to a pharmaceutical company's manufacturing process must be reported to federal regulators, ...
NRx Pharmaceuticals, Inc. announced completion of three Process Validation lots of preservative free Ketamine produced under commercial conditions in anticipation of the November 10 GDUFA Goal ...
A single type of chemical structure that shows up again and again in modern medicine is the amide bond that links a carbonyl group (C=O) to a nitrogen atom. They're so ubiquitous that 117 of the top ...
Alvotech (ALVO) said Tuesday the US Food and Drug Administration has approved a new manufacturing process for Simlandi, its biosimilar to Humira. The new process will produce the same amount in fewer ...
As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these ...
A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the University of Missouri, Cancer Targeted Technology (CTT) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results